GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » YoY EPS Growth

Noile-Immune Biotech (TSE:4893) YoY EPS Growth : 100.00% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Noile-Immune Biotech's YoY EPS Growth for the quarter that ended in Dec. 2024 was 100.00%.

Noile-Immune Biotech's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was 円0.00.

Noile-Immune Biotech YoY EPS Growth Historical Data

The historical data trend for Noile-Immune Biotech's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech YoY EPS Growth Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth
- -24.88 48.95 -176.06 18.24

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 39.57 37.07 7.14 100.00

Noile-Immune Biotech YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Noile-Immune Biotech's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(-22.28--27.25)/ | -27.25 |
=18.24 %

Noile-Immune Biotech's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Sep. 2023 )) / | Earnings per Share (Diluted) (Q: Sep. 2023 )) |
=(0--0.39)/ | -0.39 |
=100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Noile-Immune Biotech YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Noile-Immune Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » YoY EPS Growth
Comparable Companies
TSE:3750 TSE:4564 TSE:2183 TSE:4884 TSE:4891 TSE:4584 TSE:4572 TSE:130A TSE:4598 TSE:4576 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012
Website
https://www.noile-immune.com
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech Headlines

No Headlines